FDA Demands Drug Companies Pull Ads

How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.

NEW YORK The Food and Drug Administration has cited Bayer Pharmaceuticals, Schering-Plough, GlaxoSmithKline and Pfizer for misleading ads. The warning letters were released late Friday, April 15, and pertain to Pfizer’s Zyrtec allergy medicine and Levitra, the erectile dysfunction drug manufactured by Bayer but marketed in the U.S. under an agreement with Schering and GSK.

The

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in